Page 185 - Feline Cardiology
P. 185

186  Section D: Cardiomyopathies


              TREATMENT                                            After the initial diagnosis is made, periodic reevalua­
                                                                 tion could include physical examination (heart rate and
              Given  that  cats  with  dilated  cardiomyopathy  may  be   respiratory  rate),  radiographs  (for  evidence  of  heart
              taurine­deficient,  taurine  supplementation  should   failure), and blood pressure monitoring (for hypoten­
              always be given until the taurine levels have been proven   sion). A renal profile to monitor BUN, creatinine, and
              to be normal. Supplementation should be provided at   electrolytes is also helpful to monitor for complications
              250 mg orally twice day and can typically be purchased   associated with therapy. Recheck echocardiography may
              by the owner at a health food store.               be  needed  only  if  an  acute  change  occurs  (sudden
                 A positive inotrope to aid the decreased systolic dys­  decompensation to heart failure, development of signs
              function  should  be  provided.  Digoxin,  0.03125 mg     of thromboembolic disease).
              (1/4 of a 0.125 mg tablet PO q 48 hours) can be used.
      Cardiomyopathies  Pimobendan, a stronger positive inotrope, appears to be   OUTCOME AND PROGNOSIS
              well tolerated in the cat at a dose of 1.25 mg orally twice
              a day. At least in the dog, pimobendan also appears to
                                                                 The prognosis for cats with dilated cardiomyopathy is
              have other positive effects, including increased appetite,
              that may be beneficial in a cat with heart failure. However,
                                                                 a  more  gradual  progression.  In  many  cats,  if  taurine
              pimobendan  is  not  approved  for  use  in  the  cat  in    varied. Some cats progress very rapidly, and others have
              the United States and use of this drug in cats should be   deficiency is identified and treated before severe heart
              supported by client understanding and consent for off­  failure has developed the disease will begin to reverse.
              label use.                                         Cats that are successfully treated and survive the first 30
                 Treatment  should  include  additional  medications,   days  have  an  excellent  chance  of  survival  (Pion  et  al.
              including furosemide and an ACE inhibitor, as needed   1992). Substantial improvement in a cat’s attitude and
              for  the  symptoms  associated  with  congestive  heart   appetite is often observed even within the first few weeks
              failure if it is present (see Chapter 19).         of treatment (Pion et al. 1992).
                 Thoracocentesis  and/or  abdominocentsis  should     In general, prognosis is poor unless taurine deficiency
              be  performed  if  pleural  effusion  or  ascites  is  having    is present.
              an effect on respiration (see Chapter 3).
                 If atrial fibrillation or an atrial tachycardia is observed,   REFERENCES
              treatment  may  be  may  be  needed  to  slow  the  heart
              rate  (ventricular  response  rate)  as  described  (see     Boldface font indicates key references.
              Chapter 18).                                       Côté E, Harpster NK, Laste NJ, et al. Atrial fibrillation in cats: 50 cases
                                                                   (1979–2002). J Amer Vet Med Assoc 2004;225:256–260.
                 Prevention  of  possible  thromboembolic  complica­  Ferasin L, Sturgess CP, Cannon MJ, et al. Feline idiopathic cardio-
              tions should also be considered as described (see Chapter   myopathy: A retrospective study of 106 cats (1994–2001). J Fel
              20), because cats with dilated cardiomyopathy are at risk   Med Surg 2003;5:151–159.
              of thromboembolic complications.                   Fox PR Feline cardiomyopathy. In Fox PR, Sisson DD, Moïse NS, eds:
                                                                   Textbook of Canine and Feline Cardiology, 2nd ed., Philadelphia,
                                                                   WB Saunders, 1999, pp. 621–678.
                                                                 Hare J. The dilated, restrictive and infiltrative cardiomyopathies. In
              COMPLICATIONS AND MONITORING
                                                                   Bonow PO, Mann DL, Zipes DP, Braunwald E, eds. Heart Disease.
              Because  cats  with  dilated  cardiomyopathy  are  at  an   Philadelphia, Saunders Elsevier, 2008, pp. 1739–1763.
              increased risk of thromboembolic disease owners should   Lawler DF, Templeton AJ, Monti KL. Evidence for genetic involvement
                                                                   in  feline  dilated  cardiomyopathy.  J  Vet  Intern  Med  1993;7:
              be advised to observe for signs of sudden paralysis, most   383–387.
              commonly of the hindlimbs, but sometimes of a fore­  Luis Fuentes V. Diastolic functionI—Is this the key to successful man­
              limb, or atypical neurologic signs.                  agement of many feline cardiomyopathies. J Fel Med Surg 2003;
                 Congestive heart failure is a common complication.   5:51–56.
              Owners  should  be  advised  to  monitor  the  respiratory   Meurs KM, Fox PR, Magnon AL, et al. Molecular screening by poly­
                                                                   merase  chain  reaction  detects  pnaluekopenia  virus  DNA  in
              rate  at  home  in  a  resting  state. An  increase  in  resting   formalin­fixed hearts from cats with idiopathic cardiomyopathy
              respiratory rate may be a sign of developing pulmonary   and myocarditis. Cardiovasc Pathol 2000;9:119–126.
              edema or pleural effusion.                         Novotny MJ, Hogan PM, Flannigan G. Echocardiographic evidence
                 Cats  that  are  being  treated  for  atrial  fibrillation     for myocardial failure induced by taurine deficiency in domestic
                                                                   cats. Can J Vet Res 1994;58:6–12.
              with  Digoxin  should  ideally  have  a  heart  rate  of     Pion PD, Kittleson MD, Rogers GR, et al. Myocardial failure in cats
              140–160  beats/minute  on  medication  when  at  the     associated with low plasma taurine: A reversible cardiomyopa-
              clinic.                                              thy. Science 1987;237:764–768.
   180   181   182   183   184   185   186   187   188   189   190